BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37243721)

  • 1. Clinical characteristics and associated factors of qualitative olfactory dysfunction.
    Eo TS; Lee HY; Cho HJ; Yoon JH; Rha MS; Kim CH
    Rhinology; 2023 Oct; 61(5):432-440. PubMed ID: 37243721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Patient Characteristics and Olfactory Sensitivity for Trigger Odorants in Parosmia and Phantosmia.
    Sekine R; Hernandez AK; Overbeck C; Hofer MK; Mori E; Hähner A; Hummel T
    Laryngoscope; 2024 Apr; ():. PubMed ID: 38578016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative smell/taste disorders as sequelae of acute COVID-19.
    Ercoli T; Masala C; Pinna I; Orofino G; Solla P; Rocchi L; Defazio G
    Neurol Sci; 2021 Dec; 42(12):4921-4926. PubMed ID: 34557966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Parosmia and phantosmia: clinical update].
    Macario S; Hsieh JW; Daskalou D; Voruz F; Landis BN
    Rev Med Suisse; 2022 Oct; 18(798):1837-1842. PubMed ID: 36200960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and correlates of parosmia and phantosmia among smell disorders.
    Pellegrino R; Mainland JD; Kelly CE; Parker JK; Hummel T
    Chem Senses; 2021 Jan; 46():. PubMed ID: 34698820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on the prognostic significance of qualitative olfactory dysfunction.
    Reden J; Maroldt H; Fritz A; Zahnert T; Hummel T
    Eur Arch Otorhinolaryngol; 2007 Feb; 264(2):139-44. PubMed ID: 17006637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician.
    Gary JB; Gallagher L; Joseph PV; Reed D; Gudis DA; Overdevest JB
    Am J Rhinol Allergy; 2023 Jan; 37(1):95-101. PubMed ID: 35957578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Well-being in patients with olfactory dysfunction.
    Mai Y; Menzel S; Cuevas M; Haehner A; Hummel T
    Physiol Behav; 2022 Oct; 254():113899. PubMed ID: 35809697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parosmia and Phantosmia: Managing Quality Disorders.
    Altundag A
    Curr Otorhinolaryngol Rep; 2023; 11(1):19-26. PubMed ID: 36721659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Features of Parosmia Associated With COVID-19 Infection.
    Lerner DK; Garvey KL; Arrighi-Allisan AE; Filimonov A; Filip P; Shah J; Tweel B; Del Signore A; Schaberg M; Colley P; Govindaraj S; Iloreta AM
    Laryngoscope; 2022 Mar; 132(3):633-639. PubMed ID: 34870334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfactory-related Quality of Life Adjustments in Smell Loss during the Coronavirus-19 Pandemic.
    Liu DT; Prem B; Besser G; Renner B; Mueller CA
    Am J Rhinol Allergy; 2022 Mar; 36(2):253-260. PubMed ID: 34704454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19-related olfactory disorders.
    Hunter SR; Hannum ME; Pellegrino R; O'Leary MA; Rawson NE; Reed DR; Dalton PH; Parma V
    Chem Senses; 2023 Jan; 48():. PubMed ID: 36796784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical factors associated with lower health scores in COVID-19-related persistent olfactory dysfunction.
    Said M; Luong T; Jang SS; Davis ME; DeConde AS; Yan CH
    Int Forum Allergy Rhinol; 2022 Oct; 12(10):1242-1253. PubMed ID: 35032409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phantom smells: a prevalent COVID-19 symptom that progressively sets in.
    Bousquet C; Bouchoucha K; Bensafi M; Ferdenzi C
    Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1219-1229. PubMed ID: 36173444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trigeminal function in patients with COVID-associated olfactory loss.
    Juratli JH; Garefis K; Konstantinidis I; Hummel T
    Eur Arch Otorhinolaryngol; 2024 May; 281(5):2403-2411. PubMed ID: 38127097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory distortions in the general population.
    Olofsson JK; Ekesten F; Nordin S
    Sci Rep; 2022 Jun; 12(1):9776. PubMed ID: 35697904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the clinical usefulness of structured questions in parosmia assessment.
    Landis BN; Frasnelli J; Croy I; Hummel T
    Laryngoscope; 2010 Aug; 120(8):1707-13. PubMed ID: 20641087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-lasting olfactory dysfunction in COVID-19 patients.
    Prem B; Liu DT; Besser G; Sharma G; Dultinger LE; Hofer SV; Matiasczyk MM; Renner B; Mueller CA
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3485-3492. PubMed ID: 34757458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parosmia as a predictor of a better olfactory function in COVID-19: a multicentric longitudinal study for upper respiratory tract infections.
    Menzel S; Haehner A; Woosch D; Marquardt B; Ressel C; Draf J; Ottaviano G; Boscolo-Rizzo P; Kardashi R; de With K; Hackl Y; Hummel T
    Eur Arch Otorhinolaryngol; 2023 May; 280(5):2331-2340. PubMed ID: 36547711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactory and taste dysfunctions caused by COVID-19: a nationwide study.
    Miwa T; Mori E; Sekine R; Kimura Y; Kobayashi M; Shiga H; Tsuzuki K; Suzuki M; Kondo K; Suzaki I; Inokuchi G; Aiba T; Chujo K; Yagi-Nakanishi S; Tsukatani T; Nakanishi H; Nishijo M; Iinuma Y; Yokoyama A
    Rhinology; 2023 Dec; 61(6):552-560. PubMed ID: 37690065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.